Bridging the blood brain barrier
A novel technology set to overcome the challenges of the blood brain barrier is being developed in a bid to open the gates to previously unusable compounds for the treatment of central nervous system (CNS) disorders.
A novel technology set to overcome the challenges of the blood brain barrier is being developed in a bid to open the gates to previously unusable compounds for the treatment of central nervous system (CNS) disorders.
An Israeli drug delivery firm is developing a new vaginal drug delivery system, making use of bio-adhesive foams to offer a more convenient and effective treatment option for women with gynaecological complaints.
Two contract research organisations (CROs), Icon Clinical Research and Premier Research, have just announced expansions through acquisitions.
A new needle-free delivery system is taking a stab at the traditional needle and syringe after winning an award at the 2007 Medical Futures Innovation Awards.
A drug developed from the milk of transgenic animals is one step closer to being the second such drug on the market following a European thumbs up of its facilities, marking a significant move in the controversial drug development technology.
Immune Targeting Systems (ITS) has received £4m (€5.9m) to aid in its development of synthetic peptide vaccines for mutating viruses such as influenza, HIV and Hepatitis C.